Award the contract titled: "development of innate immune agonists as broad spectrum small molecule antivirals" for the base period in the amount of $1,417,922.

Ended Definitive Contract Awarded Jun 30, 2015 Last action Dec 23, 2019

Contract number: HHSN272201500011C
Awardee: Kineta Inc. UEI NSHPJSN74LP8
Awarding agency: National Institute of Allergy and Infectious Diseases National Institutes of Health, Department of Health and Human Services
Obligated: $3,676,853

Award facts

Opportunity: NIHAI2014007 Solicitation number

Targeting Therapeutics Development to Relieve Bottlenecks Award Notice · Posted Jun 13, 2014

Request for Infomration (RFI) : Optimizing Lead Therapeutic Compounds Against Infectious Pathogens - Amendment 1 Award Notice · Posted Mar 21, 2014
Contract value 100% obligated: $3,676,853.14 Current and potential, with all options
Completion date 100% complete: May 1, 2018 Current and potential, with all options
NAICS code: 541711 Research and Development in Biotechnology
PSC: AN12 Health R&D Services; Health Care Services; Applied Research
Set-aside: No set-aside
Competition: Full and Open Competition · 25 offers Negotiated Proposal / Quote
Pricing: Cost No Fee
Place of performance: Seattle, WA 98109, USA

Award details come from SAM.gov/FPDS.

Transactions

Action	Obligated	Date
Close Out P00009 · To DE-obligate remaining funds and close the contract.	-$3,789	Dec 23, 2019
Change Order 8 · The purpose of this modification is to extend the completion date of option 1 from january 31, 2018 to may 01, 2018 at no additional cost to the government.	$0	Jan 17, 2018
Change Order 7 · The purpose of this modification is to: (1) extend the option 1 completion date from september 29, 2017 to january 31, 2018; (2) to fully fund the additional…	$380,163	Sep 13, 2017
Change Order 6	$0	Jul 14, 2017
Change Order 5	$99,760	May 15, 2017
Supplemental Agreement for work within scope 4	$0	Dec 5, 2016
Change Order 3	$499,380	Aug 9, 2016
Exercise an Option 2 · Title - development of innate immune agonists as broad spectrum small molecule antivirals	$1,283,417	May 9, 2016
Other Administrative Action 1 · The purpose of this modification is to incorporate paragraph c. To article c.2. Reporting requirements, for reporting of financial conflict of interest (fcoi).	$0	Oct 28, 2015
Original award	$1,417,922	Jun 30, 2015

About this award

Written by GovTribe AI · Apr 2, 2025

The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $1,417,922 definitive cost-no-fee contract to Kineta Inc., a self-certified small disadvantaged business, for the "Development of Innate Immune Agonists as Broad Spectrum Small Molecule Antivirals" project. The contract has a ceiling value of $3,676,853.14 and a period of performance ending on May 1, 2018. This contract was not set aside and is a direct award, not associated with a larger contract vehicle.

Quick answers

Who was awarded contract HHSN272201500011C?

HHSN272201500011C was awarded to Kineta Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on June 30, 2015.

How much is contract HHSN272201500011C worth?

The government has obligated $3,676,853 on HHSN272201500011C.

Was contract HHSN272201500011C competed?

The extent of competition for HHSN272201500011C was full and open competition. The government received 25 offers.

On GovTribe

See this award's full record

Every transaction and funding action
The awardee's other awards and teaming partners
Similar awards and recompete opportunities
Ask GovTribe AI about this award

Try for free Login